![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Ambry Genetics Sues Myriad Genetics for Violating Federal Antitrust Laws
Ambry Genetics Sues Myriad Genetics for Violating Federal Antitrust Laws
August 6, 2013
Ambry Genetics has filed a counterclaim against Myriad Genetics in response to the latter’s patent infringement suit filed against Ambry in July. Ambry is claiming that Myriad is yet again engaging in anticompetitive behavior, a trend that landed Myriad in front of the Supreme Court facing accusations by more than 30 organizations in April.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
21Oct